Literature DB >> 963848

Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.

L D Hillis, J Askenazi, E Braunwald, P Radvany, J E Muller, M C Fishbein, P R Maroko.   

Abstract

The goal of this study was to determine if changes in the epicardial QRS complex after coronary artery occlusion (CAO) can be used to evaluate the efficacy of interventions designed to limit infarct size. Forty-one open-chest dogs with CAO were studied: 15 were controls, 18 received hyaluronidase and eight received propranolol starting 20 minutes after CAO. Epicardial ECGs were recorded at specific time intervals to analyze ST-segment elevation and changes in Q and R waves. Transmural specimens were obtained 24 hours after CAO from the same sites at which ECGs were recorded. Q wave development (deltaQ), R wave fall (deltaR), and their combination (deltaR + deltaQ) at 24 hours correlated with the extent of necrosis, as determined by myocardial creatine phosphokinase activity depression and histologic appearance. In the control group ST-segment elevation 15 minutes after CAO (ST15M) predicted changes in Q and R waves 24 hours later; in the treated groups, the same ST15M prior to drug administration resulted in significantly less QRS changes. Thus, 1) Q wave development and R wave fall 24 hours after CAO accurately reflect myocardial necrosis. 2) ST15M predicts subsequent changes in Q and R waves. 3) The efficacy of hyaluronidase and propranolol, agents previously shown to reduce myocardial necrosis, can be detected by less Q wave development and a smaller fall in R wave voltage.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963848     DOI: 10.1161/01.cir.54.4.591

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Usefulness of ST segment elevations as predictors of electrocardiographic signs of necrosis in patients with acute myocardial infarction.

Authors:  J Askenazi; P R Maroko; M Lesch; E Braunwald
Journal:  Br Heart J       Date:  1977-07

2.  Influence of hyaluronidase on infarct size following experimental coronary occlusion of short (90') or long (24 hrs) duration.

Authors:  M Hofmann; M Hofmann; W Schaper
Journal:  Basic Res Cardiol       Date:  1980 Mar-Apr       Impact factor: 17.165

3.  Response of the border zone to myocardial infarction in rats.

Authors:  G Olivetti; R Ricci; C Beghi; G Guideri; P Anversa
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

4.  Myocardial infarction and thrombolysis. Electrocardiographic short term and long term results using precordial mapping.

Authors:  R von Essen; W Schmidt; R Uebis; B Edelmann; S Effert; J Silny; G Rau
Journal:  Br Heart J       Date:  1985-07

5.  Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction.

Authors:  K J Hogg; K R Lees; R S Hornung; C A Howie; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1989-06

6.  Sustained effect of glucose-insulin-potassium on myocardial performance during regional ischemia. Role of free fatty acid and osmolality.

Authors:  S S Ahmed; C H Lee; H A Oldewurtel; T J Regan
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

7.  Reduction of myocardial ischemic injury with sublingual isosorbide dinitrate.

Authors:  S K Durairaj; K Venkataraman; L J Haywood
Journal:  J Natl Med Assoc       Date:  1980-11       Impact factor: 1.798

8.  Complement localization and mediation of ischemic injury in baboon myocardium.

Authors:  R N Pinckard; R A O'Rourke; M H Crawford; F S Grover; L M McManus; J J Ghidoni; S B Storrs; M S Olson
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Experimental coronary artery occlusion. I. Measurement of infarct size.

Authors:  W Schaper; H Frenzel; W Hort
Journal:  Basic Res Cardiol       Date:  1979 Jan-Feb       Impact factor: 17.165

Review 10.  Combined receptor intervention and myocardial infarction.

Authors:  D A Chamberlain; R Vincent
Journal:  Drugs       Date:  1984       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.